Feedback / Questions
isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci
https://www.businesswire.com/news/home/20221114005397/en/MyMD-Pharmaceuticals-Announces-Publication-of-Phase-1-Data-for-oral-TNF-alpha-Inhibitor-MYMD-1%C2%AE-in-Peer-Reviewed-Journal-Drug-Research
Nov 14, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next